Top Markets
Coin of the day
Pangaea Oncology, S.A. Pangaea Oncology, S.A.

Pangaea Oncology, S.A.

PANG
Classifica tra le azioni #24020
Pangaea Oncology, S.A. delivers essential medical services to cancer patients... Pangaea Oncology, S.A. delivers essential medical services to cancer patients across Spain and other European Union countries. Its extensive offerings encompass advanced molecular diagnostics, which include mutation analysis in tumor tissue and blood, gene amplification and translocation testing, immunohistochemistry, and gene expression profiling. The company is also active in clinical trials and provides in vitro drug profiling, employing techniques like MTT proliferation assays, western blotting, colony formation, migration and invasion assays, and gene silencing. Furthermore, Pangaea operates a specialized Dx platform for validating companion diagnostic platforms, benchmarking them against commercial alternatives, and offering bespoke research and development services to other diagnostic firms. A key focus also involves biomarker discovery, aiming to pinpoint novel targets for targeted therapies in their pre-clinical stages. Established in 2006, Pangaea Oncology, S.A. is headquartered in Barcelona, Spain.
Prezzo delle azioni
$1.84
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$66.03M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
-8.25%
Paese
ES
Scambia Pangaea Oncology, S.A. (PANG)

Categoria

Storico del prezzo dell'azione per Pangaea Oncology, S.A. (PANG)
Prezzo di chiusura più alto: $1.84 il 2026-08-01

Prezzo di chiusura più basso: $2.93 il 2017-09-01
Storico del prezzo dell'azione di Pangaea Oncology, S.A. dal 2017 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -2.66%
2025 8.06%
2024 15.26%
2023 2.98%
2022 -25.56%
2021 6.89%
2020 3.56%
2019 -27.13%
2018 -12.00%
2017 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$628.91 25.78%
US
$219.26 3.52%
US
$23.60 79.96%
CN
$331.56 100.22%
US
$159.25 30.93%
US